Robert E. Reiter

Dr. Reiter is a Professor of Urology and Molecular Biology and Director of the Prostate Cancer Treatment and Research Program at the David Geffen School of Medicine at UCLA. He is currently the Principal Investigator of UCLA’s SPORE (Specialized Program in Research Excellence) program, a 12 million dollar research grant from the National Cancer Institute to develop new diagnostic and treatment options for men with prostate cancer.As co-developer of ImaginAb’s technology and Chief Medical Advisor, Dr. Reiter helps ensure high clinical impact and relevance by guiding the validation studies for ImaginAb’s clinical imaging pipeline.

Dr. Reiter is a prominent figure in prostate cancer research and treatment, and is currently the Director of the Genitourinary Cancer Program in the Jonsson Comprehensive Cancer Center and the Director of Research in the Department of Urology at UCLA.Dr. Reiter completed his undergraduate studies at Yale University and then went on to study medicine at Stanford University Medical School.

Robert E. Reiter is the Founder & Chief Medical Officer at ImaginAb, based in United States, North America. With a background in Biotechnology, Robert E. Reiter has a rich history of leadership and innovation.Robert E. Reiter studied BA unknown at Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.